Table 4 |
||||
|
Optimization results in model without capacity constraints |
||||
|
Budget (€ *10^6) |
Spent in general population (%) |
Total health gains (QALY *1000) |
Gained in general population (%) |
Incremental costs per QALY |
|
|
||||
|
1 |
100 |
700 |
100 |
€1,460 |
|
|
||||
|
10 |
100 |
6,950 |
100 |
€1,460 |
|
|
||||
|
100 |
96 |
49,600 |
96 |
€3,040 |
|
|
||||
|
250 |
96 |
78,000 |
96 |
€7,230 |
|
|
||||
|
500 |
74 |
113,000 |
84 |
€8,510 |
|
|
||||
|
750 |
73 |
142,000 |
81 |
€10,900 |
|
|
||||
|
1000 |
55 |
168,000 |
68 |
€10,900 |
|
|
||||
|
2500 |
70 |
309,000 |
73 |
€13,700 |
|
|
||||
|
5000 |
77 |
516,000 |
78 |
€20,000 |
|
|
||||
|
7250 |
78 |
651,000 |
78 |
€20,800 |
|
|
||||
|
10,000 |
84 |
801,000 |
82 |
€21,700 |
|
|
||||
|
Maximal budget: 13,587 |
87 |
958,000 |
84 |
€426,000 |
|
|
||||
|
Maximal health gains and incremental costs per QALY for a range of different budgets. Model without capacity constraints. (Net present values over a lifetime horizon. Discounted rates 4% for costs and 1.5% for QALYs, price level 2007.) |
||||
|
Feenstra et al. Cost Effectiveness and Resource Allocation 2011 9:14 doi:10.1186/1478-7547-9-14 |
||||
